Press Releases
Warning
: Creating default object from empty value in
/var/www/vhosts/mimetogen.com/mimetogen.com/plugins/system/gantry/overrides/3.3/2.5/com_content/category/default_articles.php
on line
17
Mimetogen pharmaceuticals completes enrollment of mim-728 phase 3 trial for tavilermide for dry eye disease
31 March 2020
Home
The Company
Management
Board of Directors
Clinical Advisors
Investors
About Dry Eye
Research & Technology
Clinical Development
News & Publications
Press Releases
Mimetogen in the News
Publications & Presentations